medical Class II Updated 2020-10-21

Siemens Healthcare Diagnostics, Inc. recalls Atellica CH Systems Fructosamine (FRUC)-For in vitro diagnos

Recalled Product

Atellica CH Systems Fructosamine (FRUC)-For in vitro diagnostic use in the quantitative measurement of glycated protein (fructosamine) in human serum or plasma on the ADVIA¿ Chemistry systems Siemens Material Number (SMN): 11097637


Hazard / Issue

Fructosamine QC and patient samples may exhibit a 60 umol/L positive bias across the measuring range compared to predicate assay reference leading to a potential adjustment of hyperglycemic therapy. Positively biased fructosamine results may prompt changes in glucose management that may affect glycemia. In extreme situations, more aggressive management of glycemia may occur and contribute to hypoglycemia.

Issued by

FDA

Affected States: CA, DE, MD, NC, NJ, NY, PA
Lot/Code Info: All lots UDI: (01)00630414595580(10)201115(17)20210201 (01)00630414595580(10)201207(17)20210601
View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon →